NetworkNewsWire Announces Publication on the Use of …

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) — via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.

The publication, titled, “Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management,” reviews InMed’s cannabinoid manufacturing process and its potential in pain management.

To view the full publication, visit:

“Other biopharmaceutical companies may produce cannabinoids in the laboratory using more at